June 27th, 2008
UNIDENTIFIED SPEAKER: Well, good morning, and welcome to the Pfizer session this morning. We’re very pleased to have with us Dr. Joe Feczko, who is Senior Vice President and Chief Medical Officer of Pfizer. Pfizer has one of the broadest and deepest Read More
Vioxx was removed from the market in September 2004 after it was revealed that the drug increased the risk of heart attacks and strokes. Getty Images NPR.org , November 9, 2007 · Merck & Co. said Friday that it will pay nearly $5 billion to end tens Read More
The Montgomery law firm has filed 161 Bextra, Celebrex and Vioxx lawsuits to date. Montgomery, AL ( PRWEB ) April 15, 2005 — Law firm Beasley Allen, lead counsel for the first Vioxx lawsuit set for May, believes that Pfizer’s Bextra , a COX-2 Read More
Posted in Bextra | No Comments »
June 27th, 2008
8 drugs doctors wouldn't takeMSNBC - Jun 22, 2008And yet Celebrex, a COX-2 inhibitor, is still available, even though two other drugs of that class, Bextra and Vioxx, were pulled off the market due to a …
|
Read More…
Read More…
Posted in Bextra | No Comments »
June 27th, 2008
8 drugs doctors wouldn't takeMSNBC - Jun 22, 2008And yet Celebrex, a COX-2 inhibitor, is still available, even though two other drugs of that class, Bextra and Vioxx, were pulled off the market due to a …
|
Read More…
Read More…
Posted in Bextra | No Comments »
June 26th, 2008
Read More…
8 drugs doctors wouldn't takeMSNBC - Jun 22, 2008And yet Celebrex, a COX-2 inhibitor, is still available, even though two other drugs of that class, Bextra and Vioxx, were pulled off the market due to a …
|
Read More…
Discover Magazine |
Wonder Drugs That Can KillDiscover Magazine, NY - Jun 20, 2008But after he told The New York Times that the COX-2 inhibitor Bextra also caused heart attacks, the agency made a surprising move: It removed Furberg from …
|
Read More…
Read More…
Posted in Bextra | No Comments »
June 26th, 2008
UNIDENTIFIED SPEAKER: Well, good morning, and welcome to the Pfizer session this morning. We’re very pleased to have with us Dr. Joe Feczko, who is Senior Vice President and Chief Medical Officer of Pfizer. Pfizer has one of the broadest and deepest Read More
THURSDAY, Nov. 8 (HealthDay News) — Pulling the painkillers Vioxx and Bextra off the market to spare patients’ hearts may have ended up harming their stomachs, a new study suggests. Rates of gastrointestinal events serious enough to require Read More
Copyright © 2007 ScoutNews, LLC. All rights reserved. FRIDAY, Feb. 9 (HealthDay News) — A new cox-2 painkiller called etoricoxib causes fewer upper gastrointestinal problems than the traditional pain medicine diclofenac, researchers report. “In the Read More
“Faced with FDA uncertainty, a wave of upcoming patent expirations and mixed pipeline prospects, the group is no longer the defensive sector of the past,” Schott writes, citing some familiar woes . “The latest issue facing the group is Read More
FRIDAY, Nov. 9 (HealthDay News) — With Friday’s announcement of almost $5 billion to be paid out to those people claiming they were hurt by the now-withdrawn painkiller Vioxx, the drug’s maker, Merck & Co., may have hoped to end the glare of Read More
Posted in Bextra | No Comments »
June 26th, 2008
The Montgomery law firm has filed 161 Bextra, Celebrex and Vioxx lawsuits to date. Montgomery, AL ( PRWEB ) April 15, 2005 — Law firm Beasley Allen, lead counsel for the first Vioxx lawsuit set for May, believes that Pfizer’s Bextra , a COX-2 Read More
PLYMOUTH, Mass. - Alice and Ken Heckman each begin their morning by cracking open a rattling plastic tray carting scores of pills in a rainbow of pastel colors. Between the two of them, they gulp 29 pills every day: a regimen of 14 drugs, with a Read More
Beasley Allen is spearheading the review of over 31,000 claims against the manufacturers of Bextra, Celebrex, and Vioxx, having filed 161 cases to date. Montgomery, AL ( PRWEB ) April 14, 2005 — Beasley, Allen, Crow, Methvin, Portis & Miles, P.C Read More
Posted in Bextra | No Comments »
June 26th, 2008
Posted in Bextra | No Comments »
June 25th, 2008
Beasley Allen is spearheading the review of over 31,000 claims against the manufacturers of Bextra, Celebrex, and Vioxx, having filed 161 cases to date. Montgomery, AL ( PRWEB ) April 14, 2005 — Beasley, Allen, Crow, Methvin, Portis & Miles, P.C Read More
UNIDENTIFIED SPEAKER: Well, good morning, and welcome to the Pfizer session this morning. We’re very pleased to have with us Dr. Joe Feczko, who is Senior Vice President and Chief Medical Officer of Pfizer. Pfizer has one of the broadest and deepest Read More
The new rules would bar government advisers who receive money from a drug or device maker from voting on that company’s products. Expert advisers to the government who receive money from a drug or device maker would be barred for the first time Read More
Vioxx was removed from the market in September 2004 after it was revealed that the drug increased the risk of heart attacks and strokes. Getty Images NPR.org , November 9, 2007 · Merck & Co. said Friday that it will pay nearly $5 billion to end tens Read More
Posted in Bextra | No Comments »
June 25th, 2008
Discover Magazine |
Wonder Drugs That Can KillDiscover Magazine, NY - Jun 20, 2008But after he told The New York Times that the COX-2 inhibitor Bextra also caused heart attacks, the agency made a surprising move: It removed Furberg from …
|
Read More…
Read More…
Posted in Bextra | No Comments »
June 24th, 2008
Discover Magazine |
Wonder Drugs That Can KillDiscover Magazine, NY - Jun 20, 2008But after he told The New York Times that the COX-2 inhibitor Bextra also caused heart attacks, the agency made a surprising move: It removed Furberg from …
|
Read More…
8 drugs doctors wouldn't takeMSNBC - Jun 22, 2008And yet Celebrex, a COX-2 inhibitor, is still available, even though two other drugs of that class, Bextra and Vioxx, were pulled off the market due to a …
|
Read More…
Read More…
Read More…
Posted in Bextra | No Comments »
|
|
